53
|
C57BL/6 mice |
20 µg/kg/day |
Freeze injury in masseter muscle |
Single dose |
Intraperitoneal injection |
Regeneration of muscle fibres |
83
|
C57BL/6 mice |
1500 mg/kg/day |
Muscular atrophy because of streptozotocin‐induced diabetes |
2 weeks |
Oral |
Improvement of muscular atrophy |
84
|
C57BL/6 mice |
5% of daily diet |
— |
21 days |
Oral |
Reduced mitochondrial apoptosis No change in mitochondrial biogenesis adaptations in muscles |
85
|
Wistar rats |
50–100 mg/kg/day |
Endurance exercise training |
28 days |
Intraperitoneal injection |
Increase in cyclic adenosine monophosphate level and mitochondrial biogenesis in skeletal muscles |
50
|
Randomized controlled trial |
200 mg twice daily |
Downhill running test |
4 days |
Oral |
Reduced muscle pain and significant reduction in muscle injury in the lower limb |
58
|
Randomized controlled trial |
2.5 g twice daily |
Eccentric single‐leg press exercise |
5 days |
Oral |
Reduced muscular pain |